Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial

S. Senan, R. Olson, S. Harrow, S. Gaede, A. Louie, C. Haasbeek, L. Mulroy, M. Lock, G. Rodrigues, B. Yaremko, D. Schellenberg, B. Ahmad, G. Griffioen, S. Senthi, M. Liu, K. Moore, S. Currie, G. Bauman, A. Warner, D. Palma

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Article numberix170
JournalAnnals of Oncology
Publication statusPublished - Nov 2018

Cite this